Clearmind Medicine (CMND) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $6.42, +2.08% vs the prior close of $6.29.
- Volume 5.60K shares, 0.1x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CMND rises 2.1% to $6.42. Closed at $6.42, +2.08% vs the prior close of $6.29. Day range $6.24–$6.79, opened at $6.24.
CMND daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — CMND rises 2.1% to $6.42
- Closed at $6.42, +2.08% vs the prior close of $6.29. Day range $6.24–$6.79, opened at $6.24.
- Volume was 5.60K shares, 0.1x its 50-day average of 72.01K — lighter than usual.
- Price is -34.9% vs its 50-day average ($9.87) and -88.9% vs its 200-day average ($57.66).
- 52-week range $5.25–$3,840.00; today's close sits at 0% of that range, 99.8% below the 52-week high.
Oct 14, 2026 — CMND rises 0.9% to $6.29
- Closed at $6.29, +0.95% vs the prior close of $6.23. Day range $6.20–$6.47, opened at $6.36.
- Volume was 10.80K shares, 0.1x its 50-day average of 72.06K — lighter than usual.
- Price is -37.2% vs its 50-day average ($10.02) and -89.2% vs its 200-day average ($58.41).
- 52-week range $5.25–$3,840.00; today's close sits at 0% of that range, 99.8% below the 52-week high.
Oct 13, 2026 — CMND slides 4.7% to $6.23, 4 down days in a row
- Closed at $6.23, -4.74% vs the prior close of $6.54. Day range $6.23–$6.73, opened at $6.50.
- Volume was 11.00K shares, 0.2x its 50-day average of 72.78K — lighter than usual.
- Price is -38.7% vs its 50-day average ($10.17) and -89.5% vs its 200-day average ($59.26).
- 52-week range $5.25–$3,840.00; today's close sits at 0% of that range, 99.8% below the 52-week high.
- That makes 4 straight losses.
- SEC filings that day: 6-K.
Oct 12, 2026 — CMND dips 0.6% to $6.54, 3 down days in a row
- Closed at $6.54, -0.61% vs the prior close of $6.58. Day range $6.48–$6.80, opened at $6.52.
- Volume was 16.10K shares, 0.2x its 50-day average of 72.67K — lighter than usual.
- Price is -36.5% vs its 50-day average ($10.30) and -89.1% vs its 200-day average ($60.15).
- 52-week range $5.25–$3,840.00; today's close sits at 0% of that range, 99.8% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — CMND dips 0.3% to $6.58
- Closed at $6.58, -0.30% vs the prior close of $6.60. Day range $6.35–$6.94, opened at $6.77.
- Volume was 9.10K shares, 0.1x its 50-day average of 72.91K — lighter than usual.
- Price is -37.0% vs its 50-day average ($10.44) and -89.2% vs its 200-day average ($61.09).
- 52-week range $5.25–$3,840.00; today's close sits at 0% of that range, 99.8% below the 52-week high.
Oct 8, 2026 — CMND ends flat (+0.0%) to $6.60
- Closed at $6.60, +0.00% vs the prior close of $6.60. Day range $6.40–$7.16, opened at $6.64.
- Volume was 41.10K shares, 0.6x its 50-day average of 72.19K — lighter than usual.
- Price is -37.6% vs its 50-day average ($10.57) and -89.4% vs its 200-day average ($62.09).
- 52-week range $5.25–$3,840.00; today's close sits at 0% of that range, 99.8% below the 52-week high.
- SEC filings that day: 6-K.
Oct 7, 2026 — CMND jumps 13.0% to $6.60 on 2.1x normal volume
- Closed at $6.60, +13.01% vs the prior close of $5.84. Day range $5.54–$6.70, opened at $5.75.
- Volume was 146.40K shares, 2.1x its 50-day average of 70.08K — unusually heavy trading.
- Price is -38.2% vs its 50-day average ($10.67) and -89.5% vs its 200-day average ($63.15).
- 52-week range $5.25–$3,840.00; today's close sits at 0% of that range, 99.8% below the 52-week high.
- SEC filings that day: 6-K.
Oct 6, 2026 — CMND dips 2.7% to $5.84
- Closed at $5.84, -2.67% vs the prior close of $6.00. Day range $5.70–$6.18, opened at $5.89.
- Volume was 35.40K shares, 0.5x its 50-day average of 69.47K — lighter than usual.
- Price is -45.8% vs its 50-day average ($10.77) and -90.9% vs its 200-day average ($64.17).
- 52-week range $5.25–$3,840.00; today's close sits at 0% of that range, 99.8% below the 52-week high.
Oct 5, 2026 — CMND jumps 4.9% to $6.00
- Closed at $6.00, +4.90% vs the prior close of $5.72. Day range $5.25–$6.54, opened at $5.93.
- Volume was 89.20K shares, 1.3x its 50-day average of 67.77K.
- Price is -45.0% vs its 50-day average ($10.92) and -90.8% vs its 200-day average ($65.26).
- 52-week range $5.25–$3,840.00; today's close sits at 0% of that range, 99.8% below the 52-week high.
Oct 2, 2026 — CMND ends flat (-0.1%) to $5.72, a 52-week low, 3 down days in a row
- Closed at $5.72, -0.14% vs the prior close of $5.73. Day range $5.65–$5.92, opened at $5.92.
- Volume was 12.18K shares, 0.2x its 50-day average of 67.66K — lighter than usual.
- Price is -48.2% vs its 50-day average ($11.05) and -91.4% vs its 200-day average ($66.27).
- 52-week range $5.65–$3,840.00; today's close sits at 0% of that range, 99.9% below the 52-week high.
- That makes 3 straight losses.
CMND latest news & SEC filings
Every SEC filing by or about CMND in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 7, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 23, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 17, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 14, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 10, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 4, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 2, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 1, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 24, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 12, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade CMND
- How much it moves: over the last 20 sessions the average daily move was 3.48% (largest 13.0%). That is a volatile stock.
- Liquidity: about 27.12K shares (≈$174.11K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $6.42 vs a range of $5.25–$3,840.00 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:8 on Oct 5, 2026, 1:10 on May 21, 2026, 1:40 on Dec 15, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 1 open-market buys, 4 sales; latest: Financial Lp Hrt sold 22,139 shares on Jun 16, 2026.
- Latest filings: 6-K Oct 13, 2026; 6-K Oct 8, 2026; 6-K Oct 7, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
CMND market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 6.24 | 6.79 | 6.24 | 6.42 | 5.60K |
| Oct 14, 2026 | 6.36 | 6.47 | 6.20 | 6.29 | 10.80K |
| Oct 13, 2026 | 6.50 | 6.73 | 6.23 | 6.23 | 11.00K |
| Oct 12, 2026 | 6.52 | 6.80 | 6.48 | 6.54 | 16.10K |
| Oct 9, 2026 | 6.77 | 6.94 | 6.35 | 6.58 | 9.10K |
| Oct 8, 2026 | 6.64 | 7.16 | 6.40 | 6.60 | 41.10K |
| Oct 7, 2026 | 5.75 | 6.70 | 5.54 | 6.60 | 146.40K |
| Oct 6, 2026 | 5.89 | 6.18 | 5.70 | 5.84 | 35.40K |
| Oct 5, 2026 | 5.93 | 6.54 | 5.25 | 6.00 | 89.20K |
| Oct 2, 2026 | 5.92 | 5.92 | 5.65 | 5.72 | 12.18K |
| Oct 1, 2026 | 6.00 | 6.10 | 5.67 | 5.73 | 27.43K |
| Sep 30, 2026 | 6.52 | 6.72 | 6.40 | 6.44 | 12.47K |
| Sep 29, 2026 | 6.26 | 6.58 | 6.26 | 6.49 | 4.30K |
| Sep 28, 2026 | 6.40 | 6.54 | 6.26 | 6.30 | 11.38K |
| Sep 25, 2026 | 6.72 | 6.72 | 6.42 | 6.42 | 7.09K |
| Sep 24, 2026 | 6.81 | 6.81 | 6.40 | 6.48 | 7.83K |
| Sep 23, 2026 | 6.43 | 6.80 | 6.24 | 6.80 | 46.71K |
| Sep 22, 2026 | 6.24 | 6.32 | 6.18 | 6.25 | 9.35K |
| Sep 21, 2026 | 6.32 | 6.40 | 6.20 | 6.33 | 15.06K |
| Sep 18, 2026 | 6.80 | 6.86 | 6.16 | 6.39 | 23.93K |
About Clearmind Medicine
Clearmind Medicine (CMND) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in VANCOUVER, BRITISH COLUMBIA, Canada (Federal Level). State of incorporation: Canada (Federal Level). Fiscal year ends October 31. SEC CIK 1892500.
CMND board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 16, 2026 | Financial Lp Hrt | Sale | 22,139 | $3.31 |
| Jun 15, 2026 | Financial Lp Hrt | Sale | 3,183 | $3.32 |
| Jun 12, 2026 | Financial Lp Hrt | Sale | 2,102 | $3.36 |
| Jun 11, 2026 | Financial Lp Hrt | Sale | 225,191 | $0.12 |
| Jun 10, 2026 | Financial Lp Hrt | Buy | 2,159,052 | $0.15 |
CMND financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
CMND earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on CMND
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.